| Prophylaxis Against Graft Versus Host Disease |
17.0% |
| Aplastic Anaemia |
12.3% |
| Stem Cell Transplant |
10.5% |
| Immunosuppressant Drug Therapy |
9.0% |
| Immunosuppression |
8.2% |
| Bone Marrow Conditioning Regimen |
6.1% |
| Renal Transplant |
5.6% |
| Heart Transplant |
4.3% |
| Product Used For Unknown Indication |
3.4% |
| Acute Lymphocytic Leukaemia |
3.3% |
| Prophylaxis |
3.3% |
| Premedication |
2.6% |
| Renal And Pancreas Transplant |
2.6% |
| Eosinophilic Fasciitis |
2.3% |
| Langerhans' Cell Histiocytosis |
2.0% |
| Pancreas Islet Cell Transplant |
2.0% |
| Alternaria Infection |
1.6% |
| Cord Blood Transplant Therapy |
1.5% |
| Pancreas Transplant |
1.3% |
| Lung Transplant |
1.1% |
